Separation of Steviol Glycosides
Knauer Application Note
A robust, selective and sensitive separation method for the determination of four steviol glycosides in stevia plant matrix is demonstrated. In addition to the two calibrated substances two more glycosides could be found in stevia plant extracts by LC–MS. Using a popular Eurospher NH2 phase and applying moderate separation conditions results in an inexpensive and precise analysis method.
Introduction
Steviol glycosides are responsible for the sweet taste of stevia plant leaves. These compounds are 75 to 450 times sweeter than sucrose without the typical bitter aftertaste of some well-known artificial sweeteners. In the course of the accreditation of these four steviol glycosides by the public health authority a stable and sensitive analytical quantitative separation method is highly recommendable.
Figure 1
Experimental
The separation was performed in isocratic mode on a KNAUER Smartline HPLC system with low pressure gradient capability, degasser, autosampler and column oven.
Table 1
Results
The separation could be achieved in 10 minutes. The limit of detection (LOD, S/N = 3) was determined for stevioside at 7.5 ng and for rebaudioside A at 16.0 ng.
Table 2: Method performance.
Conclusion
A fast and very good separation of four steviol glycosides in Stevia leaf extract samples with excellent peak symmetry is easily accomplished by reversed-phase HPLC using the Eurospher NH2 column in combination with a Smartline HPLC system. The simple isocratic method with moderate parameters guarantees robust and sensitive results over a long time period. The method allows safe quantification. Contact info@knauer.net for a more detailed version of this application.
Knauer GmbH
Hegauer Weg 38, 14163 Berlin, Germany
tel. +49 30 809727 0 fax +49 30 801501 0
E-mail: info@knauer.net
Website: www.knauer.net
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
